Neelie T. Zacharias

Statistics

Publications

Citations

483

H-Index

Active since

2018

Affiliations

Mersana Therapeutics (United States)(Current)

Neelie T. Zacharias is an author at Mersana Therapeutics (United States) specializing in antibody conjugates, therapeutic antibody development, and pharmacy.

Publications per year

2018–2023

Publications

LRRC15+ myofibroblasts dictate the stromal setpoint to suppress tumour immunity

Akshay T. Krishnamurty, Justin A. Shyer, Minh Thai et al. · Nature · 2022 · 388 citations · Full text

Medicine, Immunology, Oncology +17

A homogeneous high-DAR antibody–drug conjugate platform combining THIOMAB antibodies and XTEN polypeptides

Neelie T. Zacharias, Vladimir N. Podust, Kimberly K. Kajihara et al. · Chemical Science · 2022 · 61 citations · Full text

Pharmacy, Biotechnology, Pharmaceutics +17

Development, Optimization, and Structural Characterization of an Efficient Peptide-Based Photoaffinity Cross-Linking Reaction for Generation of Homogeneous Conjugates from Wild-Type Antibodies

Nicholas R. Vance, Neelie T. Zacharias, Mark Ultsch et al. · Bioconjugate Chemistry · 2018 · 24 citations

Pharmacy, Biotechnology, Molecular Pharmaceutics +14

Site-Specific Dolasynthen Antibody–Drug Conjugates Exhibit Consistent Pharmacokinetic Profiles across a Wide Range of Drug-to-Antibody Ratios

Susan M. Clardy, Alex Uttard, Bingfan Du et al. · Molecular Cancer Therapeutics · 2023 · 10 citations

Pharmacy, Pharmaceutics, Pharmacology +17

1–4 of 4